Annual CFI
-$545.00 K
-$99.53 M-100.55%
01 July 2024
Summary:
Enzo Biochem annual cash flow from investing activities is currently -$545.00 thousand, with the most recent change of -$99.53 million (-100.55%) on 01 July 2024. During the last 3 years, it has risen by +$33.95 million (+98.42%). ENZ annual CFI is now -100.55% below its all-time high of $98.98 million, reached on 31 July 2023.ENZ Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$123.00 K
+$20.00 K+13.99%
01 July 2024
Summary:
Enzo Biochem quarterly cash flow from investing activities is currently -$123.00 thousand, with the most recent change of +$20.00 thousand (+13.99%) on 01 July 2024. Over the past year, it has increased by +$131.00 thousand (+51.57%). ENZ quarterly CFI is now -100.12% below its all-time high of $101.17 million, reached on 31 July 2023.ENZ Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$545.00 K
-$101.29 M-100.54%
01 July 2024
Summary:
Enzo Biochem TTM cash flow from investing activities is currently -$545.00 thousand, with the most recent change of -$101.29 million (-100.54%) on 01 July 2024. Over the past year, it has dropped by -$99.92 million (-100.55%). ENZ TTM CFI is now -100.54% below its all-time high of $100.75 million, reached on 30 April 2024.ENZ TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.5% | +51.6% | -100.5% |
| 3 y3 years | +98.4% | +88.4% | +98.4% |
| 5 y5 years | +93.3% | +55.1% | +92.6% |
ENZ Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.5% | +98.4% | -100.1% | +90.1% | -100.5% | +98.5% |
| 5 y | 5 years | -100.5% | +98.4% | -100.1% | +99.6% | -100.5% | +98.5% |
| alltime | all time | -100.5% | +99.1% | -100.1% | +99.7% | -100.5% | +99.3% |
Enzo Biochem Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$545.00 K(-100.6%) | -$123.00 K(-14.0%) | -$545.00 K(-100.5%) |
| Apr 2024 | - | -$143.00 K(+472.0%) | $100.75 M(+0.5%) |
| Jan 2024 | - | -$25.00 K(-90.2%) | $100.22 M(+0.8%) |
| Oct 2023 | - | -$254.00 K(-100.3%) | $99.38 M(+0.4%) |
| July 2023 | $98.98 M(+292.4%) | $101.17 M(<-9900.0%) | $98.98 M(-3972.5%) |
| Apr 2023 | - | -$666.00 K(-23.4%) | -$2.56 M(-109.8%) |
| Jan 2023 | - | -$869.00 K(+33.3%) | $26.00 M(+1.5%) |
| Oct 2022 | - | -$652.00 K(+76.7%) | $25.63 M(+1.6%) |
| July 2022 | $25.22 M(-173.1%) | -$369.00 K(-101.3%) | $25.22 M(+5.1%) |
| Apr 2022 | - | $27.89 M(-2347.7%) | $23.99 M(-167.2%) |
| Jan 2022 | - | -$1.24 M(+17.0%) | -$35.68 M(+2.1%) |
| Oct 2021 | - | -$1.06 M(-33.9%) | -$34.94 M(+1.3%) |
| July 2021 | -$34.50 M(+1489.7%) | -$1.60 M(-95.0%) | -$34.50 M(+0.4%) |
| Apr 2021 | - | -$31.77 M(+6178.7%) | -$34.34 M(+1101.3%) |
| Jan 2021 | - | -$506.00 K(-18.0%) | -$2.86 M(+13.8%) |
| Oct 2020 | - | -$617.00 K(-57.5%) | -$2.51 M(+15.8%) |
| July 2020 | -$2.17 M(-73.3%) | -$1.45 M(+409.1%) | -$2.17 M(+68.1%) |
| Apr 2020 | - | -$285.00 K(+78.1%) | -$1.29 M(-17.9%) |
| Jan 2020 | - | -$160.00 K(-41.6%) | -$1.57 M(-78.7%) |
| Oct 2019 | - | -$274.00 K(-52.1%) | -$7.38 M(-9.1%) |
| July 2019 | -$8.13 M(+318.0%) | -$572.00 K(+1.1%) | -$8.13 M(+3.9%) |
| Apr 2019 | - | -$566.00 K(-90.5%) | -$7.82 M(-0.4%) |
| Jan 2019 | - | -$5.97 M(+488.5%) | -$7.86 M(+214.5%) |
| Oct 2018 | - | -$1.01 M(+280.1%) | -$2.50 M(+28.5%) |
| July 2018 | -$1.94 M(+11.1%) | -$267.00 K(-55.6%) | -$1.94 M(-3.2%) |
| Apr 2018 | - | -$601.00 K(-2.3%) | -$2.01 M(-6.1%) |
| Jan 2018 | - | -$615.00 K(+33.4%) | -$2.14 M(+26.1%) |
| Oct 2017 | - | -$461.00 K(+39.3%) | -$1.70 M(-3.0%) |
| July 2017 | -$1.75 M(+15.7%) | -$331.00 K(-54.7%) | -$1.75 M(+13.6%) |
| Apr 2017 | - | -$731.00 K(+322.5%) | -$1.54 M(+22.4%) |
| Jan 2017 | - | -$173.00 K(-66.3%) | -$1.26 M(-18.1%) |
| Oct 2016 | - | -$514.00 K(+321.3%) | -$1.54 M(+1.6%) |
| July 2016 | -$1.51 M(-13.7%) | -$122.00 K(-72.8%) | -$1.51 M(-23.4%) |
| Apr 2016 | - | -$449.00 K(-0.4%) | -$1.97 M(-3.3%) |
| Jan 2016 | - | -$451.00 K(-8.0%) | -$2.04 M(+2.9%) |
| Oct 2015 | - | -$490.00 K(-16.0%) | -$1.98 M(+13.2%) |
| July 2015 | -$1.75 M(+110.3%) | -$583.00 K(+13.0%) | -$1.75 M(+18.5%) |
| Apr 2015 | - | -$516.00 K(+31.0%) | -$1.48 M(+45.8%) |
| Jan 2015 | - | -$394.00 K(+52.1%) | -$1.01 M(+30.3%) |
| Oct 2014 | - | -$259.00 K(-16.2%) | -$778.00 K(-6.6%) |
| July 2014 | -$833.00 K(-14.2%) | -$309.00 K(+494.2%) | -$833.00 K(+28.0%) |
| Apr 2014 | - | -$52.00 K(-67.1%) | -$651.00 K(-21.5%) |
| Jan 2014 | - | -$158.00 K(-49.7%) | -$829.00 K(-12.7%) |
| Oct 2013 | - | -$314.00 K(+147.2%) | -$950.00 K(-2.2%) |
| July 2013 | -$971.00 K(-113.0%) | -$127.00 K(-44.8%) | -$971.00 K(-111.0%) |
| Apr 2013 | - | -$230.00 K(-17.6%) | $8.80 M(+3.4%) |
| Jan 2013 | - | -$279.00 K(-16.7%) | $8.51 M(+13.7%) |
| Oct 2012 | - | -$335.00 K(-103.5%) | $7.48 M(+0.3%) |
| July 2012 | $7.46 M(-44.9%) | $9.64 M(-1968.6%) | $7.46 M(+36.0%) |
| Apr 2012 | - | -$516.00 K(-60.5%) | $5.49 M(-42.5%) |
| Jan 2012 | - | -$1.31 M(+265.1%) | $9.54 M(-16.8%) |
| Oct 2011 | - | -$358.00 K(-104.7%) | $11.47 M(-15.2%) |
| July 2011 | $13.54 M(-11.7%) | $7.67 M(+116.4%) | $13.54 M(+116.9%) |
| Apr 2011 | - | $3.54 M(+467.8%) | $6.24 M(-50.8%) |
| Jan 2011 | - | $624.00 K(-63.4%) | $12.70 M(-16.0%) |
| Oct 2010 | - | $1.71 M(+361.1%) | $15.11 M(-1.4%) |
| July 2010 | $15.33 M(-125.5%) | $370.00 K(-96.3%) | $15.33 M(-9.9%) |
| Apr 2010 | - | $9.99 M(+228.5%) | $17.01 M(+60.0%) |
| Jan 2010 | - | $3.04 M(+58.6%) | $10.63 M(-158.9%) |
| Oct 2009 | - | $1.92 M(-6.7%) | -$18.05 M(-70.0%) |
| July 2009 | -$60.17 M(+220.4%) | $2.06 M(-43.1%) | -$60.17 M(-23.8%) |
| Apr 2009 | - | $3.62 M(-114.1%) | -$78.92 M(-5.3%) |
| Jan 2009 | - | -$25.64 M(-36.2%) | -$83.33 M(+42.6%) |
| Oct 2008 | - | -$40.20 M(+140.9%) | -$58.43 M(+211.1%) |
| July 2008 | -$18.78 M(+1.9%) | -$16.69 M(+1996.6%) | -$18.78 M(-2.9%) |
| Apr 2008 | - | -$796.00 K(+8.0%) | -$19.35 M(+0.3%) |
| Jan 2008 | - | -$737.00 K(+31.8%) | -$19.29 M(+3.3%) |
| Oct 2007 | - | -$559.00 K(-96.8%) | -$18.67 M(+1.3%) |
| July 2007 | -$18.43 M | -$17.26 M(+2241.7%) | -$18.43 M(+360.3%) |
| Apr 2007 | - | -$737.00 K(+529.9%) | -$4.00 M(+13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2007 | - | -$117.00 K(-62.6%) | -$3.54 M(-281.5%) |
| Oct 2006 | - | -$313.00 K(-89.0%) | $1.95 M(-24.7%) |
| July 2006 | $2.59 M(-71.3%) | -$2.84 M(+950.4%) | $2.59 M(-46.3%) |
| Apr 2006 | - | -$270.00 K(-105.0%) | $4.82 M(-55.0%) |
| Jan 2006 | - | $5.37 M(+1541.3%) | $10.72 M(-0.4%) |
| Oct 2005 | - | $327.00 K(-154.2%) | $10.76 M(+19.4%) |
| July 2005 | $9.01 M(-319.8%) | -$603.00 K(-110.7%) | $9.01 M(+26.0%) |
| Apr 2005 | - | $5.63 M(+4.0%) | $7.15 M(+952.6%) |
| Jan 2005 | - | $5.41 M(-480.0%) | $679.00 K(-113.4%) |
| Oct 2004 | - | -$1.42 M(-42.2%) | -$5.08 M(+24.0%) |
| July 2004 | -$4.10 M(-75.3%) | -$2.46 M(+192.1%) | -$4.10 M(-76.3%) |
| Apr 2004 | - | -$843.00 K(+138.1%) | -$17.30 M(+2.7%) |
| Jan 2004 | - | -$354.00 K(-19.2%) | -$16.84 M(+0.4%) |
| Oct 2003 | - | -$438.00 K(-97.2%) | -$16.78 M(+1.0%) |
| July 2003 | -$16.60 M(+1375.3%) | -$15.66 M(+3926.2%) | -$16.60 M(+1172.8%) |
| Apr 2003 | - | -$389.00 K(+34.6%) | -$1.30 M(+22.2%) |
| Jan 2003 | - | -$289.00 K(+9.5%) | -$1.07 M(-5.9%) |
| Oct 2002 | - | -$264.00 K(-27.2%) | -$1.13 M(+0.8%) |
| July 2002 | -$1.13 M(-29.1%) | -$362.50 K(+138.5%) | -$1.13 M(-2.7%) |
| Apr 2002 | - | -$152.00 K(-57.3%) | -$1.16 M(-13.9%) |
| Jan 2002 | - | -$356.00 K(+39.6%) | -$1.34 M(-5.8%) |
| Oct 2001 | - | -$255.00 K(-35.2%) | -$1.43 M(-10.1%) |
| July 2001 | -$1.59 M(+27.1%) | -$393.80 K(+16.2%) | -$1.59 M(+4.3%) |
| Apr 2001 | - | -$339.00 K(-22.6%) | -$1.52 M(+1.2%) |
| Jan 2001 | - | -$438.00 K(+5.3%) | -$1.50 M(+18.8%) |
| Oct 2000 | - | -$416.00 K(+26.9%) | -$1.26 M(+1.3%) |
| July 2000 | -$1.25 M(-16.8%) | -$327.70 K(+2.1%) | -$1.25 M(-12.1%) |
| Apr 2000 | - | -$321.00 K(+60.5%) | -$1.42 M(-11.2%) |
| Jan 2000 | - | -$200.00 K(-50.0%) | -$1.60 M(+6.7%) |
| Oct 1999 | - | -$400.00 K(-20.0%) | -$1.50 M(0.0%) |
| July 1999 | -$1.50 M(+50.0%) | -$500.00 K(0.0%) | -$1.50 M(+15.4%) |
| Apr 1999 | - | -$500.00 K(+400.0%) | -$1.30 M(+18.2%) |
| Jan 1999 | - | -$100.00 K(-75.0%) | -$1.10 M(-8.3%) |
| Oct 1998 | - | -$400.00 K(+33.3%) | -$1.20 M(+20.0%) |
| July 1998 | -$1.00 M(-16.7%) | -$300.00 K(0.0%) | -$1.00 M(-16.7%) |
| Apr 1998 | - | -$300.00 K(+50.0%) | -$1.20 M(0.0%) |
| Jan 1998 | - | -$200.00 K(0.0%) | -$1.20 M(-7.7%) |
| Oct 1997 | - | -$200.00 K(-60.0%) | -$1.30 M(+8.3%) |
| July 1997 | -$1.20 M(+20.0%) | -$500.00 K(+66.7%) | -$1.20 M(0.0%) |
| Apr 1997 | - | -$300.00 K(0.0%) | -$1.20 M(+9.1%) |
| Jan 1997 | - | -$300.00 K(+200.0%) | -$1.10 M(+10.0%) |
| Oct 1996 | - | -$100.00 K(-80.0%) | -$1.00 M(0.0%) |
| July 1996 | -$1.00 M(-28.6%) | -$500.00 K(+150.0%) | -$1.00 M(+11.1%) |
| Apr 1996 | - | -$200.00 K(0.0%) | -$900.00 K(0.0%) |
| Jan 1996 | - | -$200.00 K(+100.0%) | -$900.00 K(-25.0%) |
| Oct 1995 | - | -$100.00 K(-75.0%) | -$1.20 M(-14.3%) |
| July 1995 | -$1.40 M(-6.7%) | -$400.00 K(+100.0%) | -$1.40 M(0.0%) |
| Apr 1995 | - | -$200.00 K(-60.0%) | -$1.40 M(-17.6%) |
| Jan 1995 | - | -$500.00 K(+66.7%) | -$1.70 M(+13.3%) |
| Oct 1994 | - | -$300.00 K(-25.0%) | -$1.50 M(0.0%) |
| July 1994 | -$1.50 M(+36.4%) | -$400.00 K(-20.0%) | -$1.50 M(+7.1%) |
| Apr 1994 | - | -$500.00 K(+66.7%) | -$1.40 M(+16.7%) |
| Jan 1994 | - | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Oct 1993 | - | -$300.00 K(0.0%) | -$1.20 M(+9.1%) |
| July 1993 | -$1.10 M(-42.1%) | -$300.00 K(0.0%) | -$1.10 M(-45.0%) |
| Apr 1993 | - | -$300.00 K(0.0%) | -$2.00 M(-9.1%) |
| Jan 1993 | - | -$300.00 K(+50.0%) | -$2.20 M(+37.5%) |
| Oct 1992 | - | -$200.00 K(-83.3%) | -$1.60 M(-15.8%) |
| July 1992 | -$1.90 M(-38.7%) | -$1.20 M(+140.0%) | -$1.90 M(-1050.0%) |
| Apr 1992 | - | -$500.00 K(-266.7%) | $200.00 K(-133.3%) |
| Jan 1992 | - | $300.00 K(-160.0%) | -$600.00 K(-72.7%) |
| Oct 1991 | - | -$500.00 K(-155.6%) | -$2.20 M(-29.0%) |
| July 1991 | -$3.10 M(-70.8%) | $900.00 K(-169.2%) | -$3.10 M(-71.8%) |
| Apr 1991 | - | -$1.30 M(0.0%) | -$11.00 M(+2.8%) |
| Jan 1991 | - | -$1.30 M(-7.1%) | -$10.70 M(-5.3%) |
| Oct 1990 | - | -$1.40 M(-80.0%) | -$11.30 M(+6.6%) |
| July 1990 | -$10.60 M(+32.5%) | -$7.00 M(+600.0%) | -$10.60 M(+194.4%) |
| Apr 1990 | - | -$1.00 M(-47.4%) | -$3.60 M(+38.5%) |
| Jan 1990 | - | -$1.90 M(+171.4%) | -$2.60 M(+271.4%) |
| Oct 1989 | - | -$700.00 K | -$700.00 K |
| July 1989 | -$8.00 M | - | - |
FAQ
- What is Enzo Biochem annual cash flow from investing activities?
- What is the all time high annual CFI for Enzo Biochem?
- What is Enzo Biochem annual CFI year-on-year change?
- What is Enzo Biochem quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Enzo Biochem?
- What is Enzo Biochem quarterly CFI year-on-year change?
- What is Enzo Biochem TTM cash flow from investing activities?
- What is the all time high TTM CFI for Enzo Biochem?
- What is Enzo Biochem TTM CFI year-on-year change?
What is Enzo Biochem annual cash flow from investing activities?
The current annual CFI of ENZ is -$545.00 K
What is the all time high annual CFI for Enzo Biochem?
Enzo Biochem all-time high annual cash flow from investing activities is $98.98 M
What is Enzo Biochem annual CFI year-on-year change?
Over the past year, ENZ annual cash flow from investing activities has changed by -$99.53 M (-100.55%)
What is Enzo Biochem quarterly cash flow from investing activities?
The current quarterly CFI of ENZ is -$123.00 K
What is the all time high quarterly CFI for Enzo Biochem?
Enzo Biochem all-time high quarterly cash flow from investing activities is $101.17 M
What is Enzo Biochem quarterly CFI year-on-year change?
Over the past year, ENZ quarterly cash flow from investing activities has changed by +$131.00 K (+51.57%)
What is Enzo Biochem TTM cash flow from investing activities?
The current TTM CFI of ENZ is -$545.00 K
What is the all time high TTM CFI for Enzo Biochem?
Enzo Biochem all-time high TTM cash flow from investing activities is $100.75 M
What is Enzo Biochem TTM CFI year-on-year change?
Over the past year, ENZ TTM cash flow from investing activities has changed by -$99.92 M (-100.55%)